Lenders are beginning marketing efforts for a €1.5bn ($1.75bn) financing package supporting Lone Star Funds’ acquisition of Lonza Group AG’s capsules and health ingredients business, according top a report by Bloomerg.
The report cites unnamed people familiar with the matter as revealing that the arrangement is being led by Goldman Sachs Group Inc and Jefferies Financial Group Inc, which are currently conducting early-stage discussions with a select group of investors before a wider syndication...
Continue Reading
Sign up for FREE to read the full article and access 134K+ alternative investment headlines.